Mark Friedman of Arkansas Business reports that Cantrell Pharmacy, a drug compounding operation, has settled a complaint with the Food and Drug Administration that will allow the company, which is reorganizing in bankruptcy, to stay open.

The FDA had tried to stop production on account of shortcomings it found in sanitary conditions in the drug-making process. The settlement allows Cantrell to stay open and calls for a re-inspection that Cantrell’s owner says will show the company has been operating properly.